{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:23:51Z","timestamp":1790670231596,"version":"4.1.0"},"reference-count":116,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Defense Ovarian Cancer Research Program","award":["OC160377"],"award-info":[{"award-number":["OC160377"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ovarian cancer is the leading cause of death from gynecologic malignancy in the Western world. This is due, in part, to the fact that despite standard treatment of surgery and platinum\/paclitaxel most patients recur with ultimately chemoresistant disease. Ovarian cancer is a unique form of solid tumor that develops, metastasizes and recurs in the same space, the abdominal cavity, which becomes a unique microenvironment characterized by ascites, hypoxia and low glucose levels. It is under these conditions that cancer cells adapt and switch to mitochondrial respiration, which becomes crucial to their survival, and therefore an ideal metabolic target for chemoresistant ovarian cancer. Importantly, independent of microenvironmental factors, mitochondria spatial redistribution has been associated to both tumor metastasis and chemoresistance in ovarian cancer while specific sets of genetic mutations have been shown to cause aberrant dependence on mitochondrial pathways in the most aggressive ovarian cancer subtypes. In this review we summarize on targeting mitochondria for treatment of chemoresistant ovarian cancer and current state of understanding of the role of mitochondria respiration in ovarian cancer. We feel this is an important and timely topic given that ovarian cancer remains the deadliest of the gynecological diseases, and that the mitochondrial pathway has recently emerged as critical in sustaining solid tumor progression.<\/jats:p>","DOI":"10.3390\/ijms20010229","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T03:06:06Z","timestamp":1547003166000},"page":"229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer"],"prefix":"10.3390","volume":"20","author":[{"given":"Edith","family":"Emmings","sequence":"first","affiliation":[{"name":"Masonic Cancer Center and Department of Obstetrics, Gynecology and Women\u2019s Heath, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Mullany","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center and Department of Obstetrics, Gynecology and Women\u2019s Heath, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenas","family":"Chang","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center and Department of Obstetrics, Gynecology and Women\u2019s Heath, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles N.","family":"Landen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-445X","authenticated-orcid":false,"given":"Stig","family":"Linder","sequence":"additional","affiliation":[{"name":"Cancer Center Karolinska, Department of Oncology and Pathology, Karolinska Institute, S-171 76 Stockholm, Sweden"},{"name":"Department of Medical Health Sciences (IMH), Link\u00f6ping University, S-751 85 Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bazzaro","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center and Department of Obstetrics, Gynecology and Women\u2019s Heath, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2015.12.016","article-title":"Targeting the tumour microenvironment in ovarian cancer","volume":"56","author":"Hansen","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: Implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2011.12.418","article-title":"Carcinosarcoma of the ovary: A review of the literature","volume":"125","author":"Birrer","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2015.11.004","article-title":"Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases","volume":"140","author":"Gershenson","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: A cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrc3368","article-title":"Cancer stem cell definitions and terminology: The devil is in the details","volume":"12","author":"Valent","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: Integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.mehy.2013.01.027","article-title":"The relationship between tumor size and stage in early versus advanced ovarian cancer","volume":"80","author":"Horvath","year":"2013","journal-title":"Med. Hypotheses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","article-title":"Multicellular tumor spheroids: An underestimated tool is catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"J. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The Unique Molecular and Cellular Microenvironment of Ovarian Cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","article-title":"The peritoneal \u201csoil\u201d for a cancerous \u201cseed\u201d: A comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Uruski","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","article-title":"Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/hep.1840080521","article-title":"Ascitic fluid analysis in malignancy-related ascites","volume":"8","author":"Runyon","year":"1988","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2013.12.001","article-title":"Ovarian cancer stem cells: Are they real and why are they important?","volume":"132","author":"Shah","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13048-018-0439-3","article-title":"Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors","volume":"11","author":"Parte","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2012.10.023","article-title":"Ovarian cancer stem cells: Working towards the root of stemness","volume":"338","author":"Foster","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/REP-14-0234","article-title":"Epithelial ovarian cancer stem cells: Underlying complexity of a simple paradigm","volume":"149","author":"Garson","year":"2015","journal-title":"Reproduction"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"ref_30","first-page":"194","article-title":"Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions","volume":"55","author":"Allen","year":"1987","journal-title":"Exp. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/obr.12450","article-title":"Omentum and bone marrow: How adipocyte-rich organs create tumour microenvironments conducive for metastatic progression","volume":"17","author":"Diedrich","year":"2016","journal-title":"Obes. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00109-013-1080-7","article-title":"The role of interleukin-6 in the evolution of ovarian cancer: Clinical and prognostic implications\u2014A review","volume":"91","author":"Maccio","year":"2013","journal-title":"J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1021\/acsbiomaterials.7b00069","article-title":"Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening","volume":"4","author":"Gencoglu","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1038\/srep19103","article-title":"3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained","volume":"6","author":"Zanoni","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1158\/1078-0432.CCR-17-0133","article-title":"Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids","volume":"23","author":"Raghavan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fcell.2018.00059","article-title":"Sleeping Beauty and the Microenvironment Enchantment: Microenvironmental Regulation of the Proliferation-Quiescence Decision in Normal Tissues and in Cancer Development","volume":"6","author":"Fiore","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Kalos","year":"2018","journal-title":"Oncogene"},{"key":"ref_39","first-page":"1363","article-title":"Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer","volume":"378","author":"Koole","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1038\/s41598-017-09206-0","article-title":"Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells","volume":"7","author":"Dar","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bjc.6603377","article-title":"Association of decreased mitochondrial DNA content with ovarian cancer progression","volume":"95","author":"Wang","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.mito.2010.12.015","article-title":"Respiratory competent mitochondria in human ovarian and peritoneal cancer","volume":"11","author":"Lim","year":"2011","journal-title":"Mitochondrion"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"33297","DOI":"10.18632\/oncotarget.8947","article-title":"Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycle","volume":"7","author":"Sato","year":"2016","journal-title":"Oncotarget"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbamcr.2012.11.013","article-title":"Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids","volume":"1833","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/cdd.2016.39","article-title":"Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer","volume":"23","author":"Matassa","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-016-0712-6","article-title":"Cancer stem cell metabolism","volume":"18","author":"Pestell","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-016-0555-x","article-title":"Cancer stem cell metabolism: A potential target for cancer therapy","volume":"15","author":"Deshmukh","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cdd.2013.131","article-title":"Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway","volume":"21","author":"Liu","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yexcr.2014.08.028","article-title":"Ovarian tumor-initiating cells display a flexible metabolism","volume":"328","author":"Anderson","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.18632\/oncotarget.2010","article-title":"Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation","volume":"5","author":"Pasto","year":"2014","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semcancer.2018.10.002","article-title":"Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells","volume":"53","author":"Ahmed","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fcell.2017.00038","article-title":"MYC and AMPK-Save Energy or Die!","volume":"5","author":"Haikala","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","article-title":"Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.ajpath.2017.06.012","article-title":"Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks","volume":"187","author":"Murakami","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/0008-5472.CAN-15-2906","article-title":"A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers","volume":"77","author":"Jung","year":"2017","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/1535-7163.MCT-14-0801","article-title":"Targeting c-MYC in Platinum-Resistant Ovarian Cancer","volume":"14","author":"Mangala","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":"SWI\/SNF chromatin remodeling and human malignancies","volume":"10","author":"Bieche","year":"2015","journal-title":"Annu. Rev. Pathol"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1078-0432.CCR-17-1928","article-title":"Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition","volume":"24","author":"Lang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Altieri, D.C. (2018). Mitochondrial dynamics and metastasis. Cell. Mol. Life Sci.","DOI":"10.1007\/s00018-018-2961-2"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fonc.2017.00295","article-title":"Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer","volume":"7","author":"Guerra","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbabio.2017.01.012","article-title":"Mitochondria and cancer chemoresistance","volume":"1858","author":"Guerra","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.2017.201","article-title":"Mitochondria on the move: Emerging paradigms of organelle trafficking in tumour plasticity and metastasis","volume":"117","author":"Altieri","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1349-7006.2011.01880.x","article-title":"Hypoglycemic\/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs","volume":"102","author":"Onozuka","year":"2011","journal-title":"Cancer Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yexcr.2014.01.017","article-title":"3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions","volume":"323","author":"Wenzel","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/1535-7163.MCT-14-0792","article-title":"Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer","volume":"14","author":"Senkowski","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1038\/ncomms4295","article-title":"Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4238\/2014.April.14.8","article-title":"Azithromycin enhances the favorable results of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer","volume":"13","author":"Chu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease","volume":"6","author":"Lamb","year":"2015","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Wu, W., Yu, L.H., Ma, B., and Xu, M.J. (2014). The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089841"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5468\/ogs.2016.59.4.261","article-title":"The effect of salinomycin on ovarian cancer stem-like cells","volume":"59","author":"Chung","year":"2016","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3802\/jgo.2017.28.e14","article-title":"Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell","volume":"28","author":"Lee","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s13277-015-4212-6","article-title":"Apoptotic effects of salinomycin on human ovarian cancer cell line (OVCAR-3)","volume":"37","author":"Kaplan","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbrc.2017.10.136","article-title":"Antibiotic bedaquiline effectively targets growth, survival and tumor angiogenesis of lung cancer through suppressing energy metabolism","volume":"495","author":"Wu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.18632\/aging.100983","article-title":"Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)","volume":"8","author":"Fiorillo","year":"2016","journal-title":"Aging"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00109-011-0785-8","article-title":"Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo","volume":"89","author":"Zachar","year":"2011","journal-title":"J. Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-09-1186","article-title":"Metformin in cancer therapy: A new perspective for an old antidiabetic drug?","volume":"9","author":"Tanti","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1097\/IGC.0b013e3182a80a21","article-title":"The effects of metformin on ovarian cancer: A systematic review","volume":"23","author":"Dilokthornsakul","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo","volume":"13","author":"Rattan","year":"2011","journal-title":"Neoplasia"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"479.e1","DOI":"10.1016\/j.ajog.2014.10.026","article-title":"Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models","volume":"212","author":"Lengyel","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ygyno.2012.07.115","article-title":"Metformin targets ovarian cancer stem cells in vitro and in vivo","volume":"127","author":"Shank","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Schweizer, M.T., Haugk, K., McKiernan, J.S., Gulati, R., Cheng, H.H., Maes, J.L., Dumpit, R.F., Nelson, P.S., Montgomery, B., and McCune, J.S. (2018). A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202709"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e1930","DOI":"10.1038\/cddis.2015.263","article-title":"Early effects of the antineoplastic agent salinomycin on mitochondrial function","volume":"6","author":"Manago","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Klose, J., Eissele, J., Volz, C., Schmitt, S., Ritter, A., Ying, S., Schmidt, T., Heger, U., Schneider, M., and Ulrich, A. (2016). Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt\/beta-catenin signaling in CD133(+) human colorectal cancer cells. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2879-8"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2011.05.030","article-title":"Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells","volume":"313","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3892\/or.2013.2241","article-title":"Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: Involvement of p38 MAPK activation","volume":"29","author":"Zhang","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bbrc.2013.12.032","article-title":"Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3892\/or.2015.4253","article-title":"Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells","volume":"34","author":"Zhang","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/1535-7163.MCT-12-1243","article-title":"A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide","volume":"12","author":"Bodapati","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41419-017-0092-6","article-title":"Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer","volume":"9","author":"Alasadi","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1038\/s41388-018-0340-y","article-title":"Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide","volume":"37","author":"Lu","year":"2018","journal-title":"Oncogene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1158\/1078-0432.CCR-15-2256","article-title":"Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma","volume":"22","author":"Satoh","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Wang, Y.C., Chao, T.K., Chang, C.C., Yo, Y.T., Yu, M.H., and Lai, H.C. (2013). Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074538"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-17-2697","article-title":"Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor","volume":"24","author":"Vitiello","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1349-7006.2004.tb03330.x","article-title":"Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-me thyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation","volume":"95","author":"Esumi","year":"2004","journal-title":"Cancer Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-2-12","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"2","author":"Andrzejewski","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Sesen, J., Dahan, P., Scotland, S.J., Saland, E., Dang, V.T., Lemarie, A., Tyler, B.M., Brem, H., Toulas, C., and Cohen-Jonathan Moyal, E. (2015). Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123721"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1158\/1535-7163.MCT-16-0793","article-title":"Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts","volume":"16","author":"Phyo","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cam4.112","article-title":"BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I","volume":"2","author":"Ellinghaus","year":"2013","journal-title":"Cancer Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-015-0138-0","article-title":"Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth","volume":"3","author":"Schockel","year":"2015","journal-title":"Cancer Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia","volume":"7","author":"Ashton","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ol.2017.6103","article-title":"Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer","volume":"14","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_113","first-page":"1588","article-title":"Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer","volume":"62","author":"Duivenvoorden","year":"2002","journal-title":"Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Skrtic","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/fcp.12199","article-title":"Tigecycline targets nonsmall cell lung cancer through inhibition of mitochondrial function","volume":"30","author":"Jia","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2017.01.021","article-title":"Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage","volume":"483","author":"Tan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/1\/229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:24:25Z","timestamp":1760185465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/1\/229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["ijms20010229"],"URL":"https:\/\/doi.org\/10.3390\/ijms20010229","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]}}}